|
Volume 271, Number 39,
Issue of September 27, 1996
pp. 23786-23791
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Regulation of ITAM Signaling by Specific Sequences in Ig- B
Cell Antigen Receptor Subunit*
(Received for publication, May 3, 1996)
Sylvanie
Cassard
§¶,
Daniel
Choquet
'',
Wolf Herman
Fridman
and
Christian
Bonnerot
¶
From CJF 95-01, INSERM, Institut Curie, 75231 Paris
cedex 05, Unité 261, INSERM, Institut Pasteur, Paris, and
Unité 255, INSERM, Institut Curie,
75231 Paris cedex 05, France
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES
ABSTRACT
B cell antigen receptors (BCR) are composed of an
antigen binding subunit, the membrane Ig, and Ig- /Ig-
heterodimers, that contain a transducing motif named ITAM for
``immuno-receptor tyrosine-based activation motif.'' Ig- and
Ig- ITAMs only differ by four amino acids located before the second
conserved tyrosine (DCSM in Ig- and QTAT in Ig- ), which determine
the in vitro association of Ig- with the src
kinase fyn. We have previously shown that Ig- and Ig-
BCR subunits activate different signaling pathways by expressing, in B
cells, Fc RII chimeras containing the cytoplasmic tails of Ig- or
Ig- . We report here that the signaling capacity of Ig- ITAM is
regulated by peptide sequences located inside (QTAT region) or outside
the ITAM (flanking sequences). Furthermore, when isolated, Ig- and
Ig- ITAM have similar abilities as the entire Ig- tail and the
whole BCR in triggering tyrosine kinase activation, an increase of
intracellular calcium concentration as well as late events of cell
activation as assessed by cytokine secretion. These data show that
alterations that modify the ability of Ig- and Ig- to interact
in vitro with the src kinase fyn
(switch between QTAT and DCSM) also determine signal transduction
capabilities of these molecules expressed in B cells.
INTRODUCTION
The transducing capacities of BCR1 are
based on its multimolecular structure. BCRs are composed of antigen
binding units, the membrane immunoglobulins (mIg), noncovalently
associated with transducing subunits, the Ig- /Ig- heterodimers.
The cytoplasmic tails of these associated chains become phosphorylated
after cross-linking of mIg (1) and associate with intracellular
effectors (2) including the src kinases lyn,
fyn, blk, lck (3, 4, 5, 6), and the
src-related kinase syk (7, 8), as well as other
kinases such as PI-3 kinase and unidentified phosphoproteins (9). By
adsorbing B cell lysates on fusion proteins containing the cytoplasmic
domains of Ig- or Ig- , the unphosphorylated cytoplasmic domains
were shown to bind to different kinases. The cytoplasmic tail of Ig-
interact with fyn and lyn and with an
unidentified molecule of 38 kDa, whereas the cytoplasmic tail of Ig-
binds to two unidentified phosphoproteins of 40 and 42 kDa (9). The
activation of tyrosine kinase is followed by an increase of
intracellular calcium concentration (10). Typical cytoplasmic calcium
increase includes an initial release of calcium from intracellular
stores followed by an influx of extracellular calcium, which is
involved in lymphocytes activation (11, 12). However, both cytoplasmic
domains of Ig- and Ig- , like associated subunits of T cell
antigen receptors or Fc receptors, contain an ITAM (immunoreceptor
tyrosine-based activation motif), which contains conserved tyrosine and
leucine or isoleucine amino acids
(YXX(L/I)XXXXXXXYXX(L/I)) (13). One
particularity of Ig- and Ig- ITAMs is their high homology because
they mostly differ by the four amino acids located before the second
conserved tyrosine, the same four residues determining the in
vitro association of Ig- with fyn (14).
Functional analysis of Ig- and Ig- cytoplasmic domains in B cells
established that both are able to induce an increase of intracellular
calcium concentration (15, 16, 17) with qualitative differences (18).
Although Ig- was as efficient as Ig- in triggering
protein-tyrosine kinase activation, only Ig- -containing chimeras
were able to trigger an efficient signal transduction leading to an
extracellular calcium influx and interleukin-2 (IL-2) production in the
IIA1.6 B cell line. Ig- triggered an oscillatory release from
intracellular calcium stores and no IL-2 secretion (18). Ig- and
Ig- cytoplasmic domains therefore possess their own distinct
signaling capabilities. In this study, the molecular basis of the
different signaling capacities of Ig- and Ig- cytoplasmic tails
were analyzed. We showed that BCR subunits transducing activities are
based on the ITAM conserved sequence, but they may be regulated by
unconserved sequences located inside or outside the motif.
MATERIALS AND METHODS
Plasmid Construction
Ig- and Ig- chimeras were
constructed by adding the sequences encoding the putative cytoplasmic
domains of Ig- and Ig- to the extracellular and transmembrane
domains of cDNA encoding mouse Fc RII (FcR) by recombinant
polymerase chain reaction as described previously (18). Site-directed
mutagenesis of the Ig- and Ig- chimeras was also performed using
polymerase chain reaction. The resulting constructions were inserted in
SR -driven expression vector and then were sequenced.
Cell Culture and Transfection
The B lymphoma IIA1.6 is a
Fc R-defective variant of A20 B cells that grows in RPMI 1640 containing 10% fetal calf serum, 10 mM glutamine, 100 units/ml penicillin, 100 µg/ml streptomycin, 50 µM
2-mercaptoethanol, and 5 mM sodium pyruvate (Life
Technologies, Inc.). These cells express endogenous mIgG2a. The chimera
constructs were linearized with ScaI. 72 h after
transfection, the cells were transferred to Geneticin-containing medium
(G418, 1 mg/ml; Life Technologies, Inc.). The geneticin-resistant cells
were checked by fluorescence-activated cell sorter analysis for Fc R
expression using the monoclonal antibody 2.4G2 (31), and cells were
cloned.
Detection of Tyrosine Phosphorylated Proteins
Cells were
preincubated at 4 °C with or without 10 µg/ml of 2.4G2 for 15 min
and then washed twice with RPMI. 3.5 × 105 cells were
then stimulated by F(ab )2 fragments of mouse anti-rat IgG
antiserum (50 µg/ml) at 37 °C for the indicated times. As a
positive control, 2.4G2 untreated cells were stimulated by
F(ab )2 fragments of anti-mouse IgG antibodies (15 µg/ml). At different times, the stimulated cells were lysed with 2%
SDS and immediately boiled for 5 min. Proteins were precipitated by
acetone for 30 min on ice and pelleted by centrifugation for 5 min at
10,000 × g. The samples were then analyzed on 8%
polyacrylamide-SDS gels and transferred on nitrocellulose filters
(Schleicher & Schull). Red Ponceau staining of the proteins on the
filters allowed verification of the transfer efficiency and the
homogeneity between the different lanes. The filters were incubated for
2 h at room temperature in Tris-buffered saline containing 5%
bovine serum albumin and then incubated overnight at 4 °C in
Tris-buffered saline/5% bovine serum albumin with the
anti-phosphotyrosine monoclonal antibody Py20 coupled to HRP (ICN
Flow). After washing with Tris-buffered saline containing 0,05% Triton
X-100, the filters were incubated for 1 min with the Western blotting
Reagent ECL (Amersham Corp.), and chimioluminescence was detected by
exposure of the filters to X-Omat films (Kodak) for 30 s to 15 min.
Measurement of IL-2 Secretion
IL-2 release by transfected
IIA1.6 B cells (105 cells/well), stimulated for 16 h
under the same conditions as for the induction of tyrosine
phosphorylations, was determined by monitoring the growth of the
IL-2-dependent cell line CTL.L2. For the IL-2 measurement
after stimulation without extracellular calcium, either 1 mM of EGTA was added in the standard medium (the viability
of the cells was verified with trypan blue) or a calcium-free medium
was used (Life Technologies, Inc.). 104 CTL.L2 cells
(supernatant free) were cultured for 24 h at 37 °C with
supernatants from the activation assays. The cultures were
pulse-labeled with 0.5 µCi of [3H]thymidine (25 mCi/mmol, CEA, Gif-sur-Yvette, France) for the last 6 h of the
culture period before harvesting the cells using a multiple cell
harvester (Osi, Paris, France). The incorporated thymidine was detected
by scintillation counting. The IL-2 secreted by mutant chimeras was
compared with the IL-2 secreted, during the same experiment, by the
same cells after stimulation of endogenous membrane IgG. The values
obtained with supernatants of anti-IgG-stimulated cells were ranging
from 2 × 104 to 8 × 104 cpm
depending of the clones. To compare all the clones, the values were
therefore normalized on mIgG stimulation, which represents the maximum
of stimulation.
Measurement of Intracellular Calcium Concentrations
Digital
calcium imaging experiments were performed on fura-2 (Molecular Probes
Eugene, OR) loaded cells (0.25 µM 15 min at 37 °C in
culture medium, 106 cells/ml) as previously described
(18). The averages of intracellular calcium changes were calculated
with 50-100 single cell measurements.
RESULTS
The intracellular signaling activity of mIg-associated subunits,
Ig- and Ig- , was analyzed by expressing, in the B cell line
IIA1.6, chimeras fusing the cytoplasmic domain of either Ig- or
Ig- to the extracellular and transmembrane domains of Fc RII. Both
chimeras activated tyrosine kinases (Fig.
1a), but only Ig- chimeras (c.Ig- )
stimulation induced intracellular calcium modifications composed of an
initial release from intracellular stores followed by an extracellular
calcium influx, whereas Ig- chimeras (c.Ig- ) stimulation
triggered an oscillatory release of calcium from intracellular stores
(Fig. 1b) (18). Interestingly, only Ig- chimeras,
as well as endogenous mIg, were efficient to induce the secretion of
cytokines.
Fig. 1.
Ig- and Ig- cytoplasmic tails activate
distinct signaling pathways. a, chimeras were preincubated
with the rat anti-FcR antibody 2.4G2 (10 µg/ml), and the stimulation
was triggered by the F(ab) 2 antiserum mouse anti-rat (50 µg/ml) for the indicated times. After separation on SDS-8%
polyacrylamide gels, the proteins were immunoblotted with the
horseradish peroxidase-coupled anti-phosphotyrosine monoclonal antibody
Py20. The arrow indicates the phosphoproteins induced by the
cross-linking of mIg, which peak at 2 min. b, arithmetic
average of intracellular calcium concentration measurements at the
single cell level in a standard medium after cross-linking of the
Ig- or the Ig- chimeras. The arrow indicates the
triggering of stimulation. The boxed curve represents an
example of a single cell response. c, measurement of IL-2
production after cross-linking of Ig- and Ig- chimeras.
Cross-linking of Ig- chimeras without extracellular Ca2+
inhibits IL-2 secretion. Chimeras were cross-linked in the same
conditions than above overnight at 37 °C in a standard medium
containing or not 1 mM EGTA or in a Ca2+ free
medium. The IL-2 secretion induced by Ig- chimeras was restored by
the addition of 1 mM of Ca2+ in the media. The
results were normalized on the mIg responses, which represent the
maximum of IL-2 secretion.
[View Larger Version of this Image (42K GIF file)]
The role of calcium influx in B cell signaling was analyzed by
measuring IL-2 secretion after stimulation of Ig- chimera or mIgG in
conditions that prevented the extracellular calcium influx. Cells
expressing c·Ig- were incubated with EGTA to chelate the
extracellular calcium or in a calcium free medium. Cross-linking of
c.Ig- or of mIgG in the 1 mM EGTA-containing medium (or
in calcium-free medium) prevented calcium influx (data not shown) and
IL-2 secretion by transfected cells (Fig. 1c). Both
signaling events were restored by adding 1 mM
CaCl2. Extracellular calcium influx is therefore required
for the triggering of cytokine secretion after cross-linking of Ig-
chimera or the whole BCR. Moreover, although the cytoplasmic tail of
Ig- and Ig- both contain an ITAM, only Ig- induced efficient
signal transduction. Ig- therefore accounts for the ability of BCR
to induce calcium influx and subsequent cell activation events. Peptide
sequence of Ig- and Ig- ITAM must determine their interactions
with specific cytoplasmic effectors that induce either calcium influx
and cytokine secretion or calcium oscillatory release.
Requirements of the Conserved ITAM Tyrosine Residues for the
Signaling Capacities of Ig- and Ig- Tails
To identify the
peptide sequences of Ig- and Ig- cytoplasmic tails involved in
the induction of calcium influx, a mutational analysis was performed by
using FcR-based chimeras (see Table I). The cytoplasmic tails of Ig-
and Ig- were shown to interact with different tyrosine kinases, and
the phosphorylation of conserved tyrosine residues constituting their
ITAM enhanced these interactions. To evaluate in our model the role of
the tyrosine residues present in the ITAM, they were individually
mutated to alanine in the cytoplasmic domain of Ig- (c.Ig- A23
and c.Ig- A34) or mutated together in the Ig- tail (c.Ig-
A15,A26). These constructions were stably expressed in IIA1.6
cells, and surface expressions were evaluated by flow cytometry using
indirect immunofluorescence (Fig. 2).
Fig. 2.
Surface expression of Ig- and Ig-
chimeras in IIA1.6 transfected cells by indirect fluorescence.
Cells were incubated with the anti-FcR antibody 24G2 and then with the
fluorescein-conjugated mouse anti-rat IgG antiserum (white
histograms). The dark histograms represent the control
experiments where the cells were only incubated with the
fluorescein-coupled antibodies.
[View Larger Version of this Image (23K GIF file)]
The earliest known BCR signaling event is tyrosine kinase activation
leading to a cascade of intracellular protein phosphorylations. Our
previous results showed that the cytoplasmic domains of Ig- and
Ig- are able to trigger phosphorylation of similar major
intracellular proteins (Fig. 1a). As expected, c.Ig- A23
and c.Ig- A34 or c.Ig- A15,A26 were inefficient to trigger
tyrosine phosphorylation of intracellular proteins, whereas in control
experiments, stimulation of mIg triggered tyrosine phosphorylation in
all the transfectant cells (Fig. 3a). The
stimulation of these mutated chimeras was also inefficient to induce
any changes of the intracellular calcium concentration, as measured at
the single cell level by video imaging (Fig. 3b), and they
did not trigger IL-2 secretion (Fig. 3c). All the
transfected cells were responsive to stimulation via mIg. Ig- and
Ig- cytoplasmic tails trigger two different signaling pathways,
which are therefore both dependent on ITAM tyrosine residues. As shown
by others (15, 19, 20, 21), the conserved tyrosines residues are required
for the induction of transmembrane signaling through Ig- and Ig- .
Because both chains activate different signaling pathways, some Ig-
or Ig- specific amino acids must modulate their signaling
activities.
Fig. 3.
The mutation of the tyrosine residues in the
entire cytoplasmic tail of Ig- (c.Ig- A23 and c.Ig- A34) or
Ig- (c.Ig- A15,A26) prevent the triggering of intracellular
signaling events. Chimeras were cross-linked in the same
conditions as before. a, tyrosine phosphorylations of
intracellular proteins after cross-linking of chimeras
(anti-chimeras) or endogenous mIg (anti-IgG).
b, measurement of intracellular Ca2+
concentrations at the single cell level after cross-linking of mutant
chimeras (arithmetic averages). The arrows indicate the
triggering of stimulation. The dotted arrows indicate the
control-stimulation experiments where the endogenous mIg were
cross-linked. Boxed curves represent examples of a single
cell response. c, IL-2 secretion by the cells expressing
chimeras. Chimeras were cross-linked as before
(anti-chimera), and in the control experiments, mIg were
cross-linked with 15 µg/ml of F(ab) 2 fragments of rabbit
anti-mouse IgG (anti-IgG). The results presented here are
the means of three experiments done in duplicate and are normalized on
the mIg responses, which represent the maximum of IL-2 secretion.
[View Larger Version of this Image (24K GIF file)]
Four Amino Acids in the ITAM Determine the Signaling Capabilities
of Ig- and Ig- Cytoplasmic Domains
One major difference
between Ig- and Ig- ITAM consists of four amino acids preceding
the second tyrosine of the motifs. The peptide sequence DCSM is present
in Ig- , whereas Ig- contains the sequence QTAT. This difference
has been related to the specific binding of src family
kinases to the cytoplasmic tails of Ig- or Ig- . In a
nonphosphorylated status, only the molecules bearing the four amino
acids DCSM bind the tyrosine kinase fyn (14). The role of
these four amino acids in the signaling activity of Ig- and Ig-
was investigated by expressing two chimeras containing a switch of the
sequences QTAT versus DCSM in Ig- and Ig- cytoplasmic
tails (c.Ig- QTAT and c.Ig- DCSM) (see Table I and Fig. 2). The
cross-linking of c.Ig- DCSM triggered the phosphorylation of
numerous intracellular proteins and an extracellular calcium influx
leading to IL-2 secretion (Fig. 4, a,
b, and c). The exchange of QTAT by DCSM inside
the entire Ig- cytoplasmic domain was therefore sufficient to
convert the transducing phenotype of Ig- in that of Ig- tail.
Because the cross-linking of c.Ig- was not able to trigger a calcium
influx, the capacity of c.Ig- and c.Ig- DCSM to trigger a calcium
influx is probably determined by the presence of the DCSM polypeptide
sequence in their cytoplasmic tail. In contrast, the conversion of the
DCSM sequence into QTAT in the Ig- tail did not prevent the
triggering of calcium influx and tyrosine kinase activation (Fig. 4,
a, b, and c). In all these
experiments, the transfectant cells were responsive to anti-IgG. The
results obtained with the switching mutants showed that the ability of
Ig- to trigger different intracellular events may be modulated by
amino acids located between the conserved ITAM residues, whereas the
similar switch (QTAT) in the entire Ig- cytoplasmic tail does not
affect its signaling capacity. The conformation induced by the peptide
sequences surrounding Ig- ITAM must be important to induce its
interactions with specific intracellular effectors.
Fig. 4.
The inversion of the peptide sequences DCSM
and QTAT change the transducing capacities of Ig- and Ig-
cytoplasmic domains. a, tyrosine kinase activation after
cross-linking of the two chimeras containing the inversion (c.Ig-
DCSM and c.Ig- QTAT) in the same conditions than before.
b, intracellular calcium measurement after cross-linking of
the chimeras. As before, the arrows show the addition of the
second antibody to cross-link the chimeras, and the dotted
arrows indicate the addition of F(ab) 2 fragments of
rabbit anti-mouse IgG. Boxed curves show examples of a
single cell response. c, IL-2 secretion after cross-linking
of the chimeras or after cross-linking of mIg for control experiments.
The measurements were done in the same conditions as in Fig. 3.
[View Larger Version of this Image (39K GIF file)]
The Activity of Ig- ITAM Is Regulated by Flanking
Sequences
The sequences flanking the two motifs are different
between Ig- and Ig- cytoplasmic tails. To test whether flanking
sequences affect the signaling capacities of ITAMs, chimeras containing
isolated Ig- or Ig- motifs (c.Ig- m and c.Ig- m; Table
I) were expressed in IIA1.6 cells (Fig. 2). The
stimulation of c.Ig- m induced tyrosine phosphorylation of several
intracellular substrates similar to those induced by the cross-linking
of c.Ig- , with a maximum of phosphorylation intensity after 1 min of
stimulation (Fig. 5a). The pattern of calcium
signaling obtained after cross-linking of c.Ig- m was similar to the
pattern obtained after stimulation of c.Ig- , comprising a release of
calcium from the intracellular stores and an influx of extracellular
calcium (Fig. 5b). This calcium response triggered by the
cross-linking of c.Ig- m was followed by later events of signals
transduction, as measured by IL-2 secretion (Fig. 5c). Thus,
when isolated, the Ig- ITAM was as efficient as the entire Ig-
cytoplasmic tail and as the whole BCR in triggering cytokine
production. The ITAM of Ig- is therefore fully functional inside the
entire Ig- tail environment, and it is not regulated directly by its
flanking sequences.
Fig. 5.
Ig- ITAM functions as the entire
cytoplasmic tail of Ig- , whereas the motif of Ig- does not
function as the entire intracellular domain of Ig- . a,
intracellular protein phosphorylation induced by the cross-linking of
the chimeras for the indicated times. The cells were also stimulated by
their endogenous mIgG (arrow). b, measurement of
intracellular calcium concentration after cross-linking of chimeras
containing the Ig- or Ig- ITAM (c.Ig- m and c.Ig- m,
respectively). The arrows indicate the triggering of the
stimulation, and the boxed curves represent an example of a
single cell response. c, stimulation of both chimeras
triggered IL-2 secretion. The cells all produced IL-2 after
cross-linking of mIgG. This experiment was done under the same
conditions as described in the legend to Figs. 3 and 4.
[View Larger Version of this Image (39K GIF file)]
Surprisingly, the isolated Ig- ITAM had different signaling
abilities than the entire cytoplasmic tail of Ig- . In contrast to
intracellular calcium oscillations induced by Ig- chimeras, the
cross-linking of c.Ig- m triggered a complete calcium response
composed of an initial calcium release from intracellular stores
followed by an extracellular calcium influx (Fig. 5b), like
the cross-linking of mIg, c.Ig- , or c.Ig- m. Moreover, the
stimulation of c.Ig- m was very efficient in inducing IL-2 secretion
(Fig. 5c). In contrast, no clear differences of
phosphoproteins were detected after cross-linking of c.Ig- m or
c.Ig- , whereas the maximum intensities of the phosphorylations were
respectively observed after 2 and 1 min of cross-linking (Figs.
1a and 5a). Thus, the isolated Ig- ITAM and
the entire cytoplasmic tail of Ig- are both able to activate
tyrosine kinases but differ in terms of calcium signaling and
triggering of IL-2 secretion.
These results show that the two isolated Ig- and Ig- ITAMs are
able to trigger the same intracellular events leading to cytokine
production and that the unconserved environment of an ITAM can regulate
the signaling activity of this kind of tyrosine-based activating
motifs.
DISCUSSION
Stimulation of BCR triggers intracellular events such as protein
kinase activation and increase of intracellular calcium concentration
resulting in cell activation. In the present work, we evaluated the
relative contributions of different domains of Ig- and Ig-
cytoplasmic tails in B cell signaling. The cytoplasmic domain of
Ig- , and more specifically its ITAM, reflects the transducing
capacities of the whole BCR in terms of phosphoproteins induction,
calcium mobilization, and IL-2 secretion, which is dependent on the
triggering of a calcium influx. In contrast, Ig- ITAM activity is
modulated by amino acids located between the conserved residues and by
the ITAM flanking sequences, although the signaling capacities of both
ITAMs require conserved tyrosine residues.
The transducing events triggered by Ig- ITAM are similar to those
triggered by the entire intracellular domain of Ig- and by the whole
BCR. In this cascade of intracellular signaling events, the triggering
of extracellular calcium influx is a crucial step of B cell activation,
which may be inhibited by the cross-linking of mIg with FcR for IgG
(22, 23, 24). In addition, chelation of extracellular calcium with EGTA
inhibits the triggering of both calcium influx and lymphokine secretion
after stimulation of either BCR or Ig- chimeras (Fig.
1c). Furthermore, Ig- chimera stimulation did not
efficiently induce lymphokine secretion, although this molecule
triggered intracellular tyrosine phosphorylation and oscillatory
releases of intracellular calcium stores without extracellular influx
(18). It has been shown that in T cells, IgM-Ig- and CD8-Ig-
chimeras were able to trigger IL-2 after cross-linking (20, 17), but T
cells could lack an intracellular effector that regulates Ig-
activity in B cells. The triggering of late B cell activation events as
assessed by lymphokine secretion is therefore based on the signaling
capacities of Ig- cytoplasmic domain, which may be reduced to its
ITAM.
The Ig- and Ig- cytoplasmic tails therefore triggered distinct
intracellular events, whereas, strikingly, the isolated ITAMs have the
same efficient transducing capacities. Stimulation of both chimeras
containing the isolated motifs induced the phosphorylation of the same
intracellular substrates and triggered both calcium influx and IL-2
secretion. These results are consistent with data obtained with similar
µCD8-based chimeras containing the isolated ITAM of Ig- or Ig-
(25). They showed that cross-linking of these chimeras triggered the
same protein tyrosine phosphorylations and calcium mobilization and
induced the interaction of the motifs with the same kinases
lyn, fyn, and syk. Another study has
also shown that phosphorylated ITAMs of Ig- or Ig- have similar
abilities to interact with fyn in vitro (14). The
phosphorylation of the ITAM tyrosine therefore seems to be a crucial
step to induce the transducing cascade because the mutation of
ITAM-conserved tyrosine residues totally abolished the signaling
capabilities of both Ig- and Ig- cytoplasmic tails (Fig. 3; Refs.
15 and 19, 20, 21), perhaps by preventing the interaction with
fyn or with other kinase(s). Therefore, as already
described, the ITAM-tyrosine residues are required to give to Ig-
and Ig- their transducing capabilities.
The specificity of Ig- and Ig- tails to trigger different
signaling events seems determined by nonconserved sequences between the
cytoplasmic tails of Ig- and Ig- . One of the differences between
the two ITAM-amino acid sequences is constituted of four amino acids
located between the conserved tyrosine residues (DCSM in Ig- and
QTAT in Ig- ). Our results show that this difference of four amino
acids do not seem to play a role in the transduction events triggered
by the isolated motifs (Fig. 5), but it is important when the motifs
are examined in their entire cytoplasmic environment. Indeed, the
conversion of the four amino acids QTAT into DCSM in the Ig-
cytoplasmic tail changed the signaling activity of Ig- into those of
Ig- (Fig. 4), perhaps by enhancing the basal level of fyn
associated with the chimera, because only the DCSM-bearing ITAMs were
able to interact with fyn in vitro (14). In contrast, when
the amino acids DCSM were changed into QTAT in Ig- cytoplasmic tail,
the transducing capacities of Ig- were not switched, showing that
QTAT is necessary but not sufficient to inactivate the calcium influx
and/or to activate calcium oscillations. These results indicate that
there are other amino acids inside or outside the Ig- ITAM that also
regulate its signaling capacities.
The ITAM of Ig- , in contrast to the entire cytoplasmic domain of
Ig- , is fully efficient to trigger intracellular events leading to
lymphokine secretion. This indicates that ITAM flanking sequences
regulate the activity of the Ig- ITAM. These sequences are
inefficient, however, when the four amino acids QTAT are replaced by
DCSM (Fig. 4). This suggests that other amino acids that differ between
the two motifs, like the four amino acids located before the first
tyrosine of the two motifs (DENL in Ig- and EDHT in Ig- ), may
play a role in the regulation capacity of flanking regions of Ig-
ITAM. This sequence could regulate the Ig- ITAM by interacting with
intracellular proteins, like the two unidentified p40 and p42
phosphoproteins (9), which bind specifically to Ig- . Two
nonexclusive models may be proposed to account for the specificity of
Ig- and Ig- intracellular signaling. First, the nonconserved
sequences located inside or outside the ITAM induce conformational
modifications, which modulate the affinity of cytoplasmic effectors for
conserved tyrosine residues located in the ITAM. Second, each domain of
the cytoplasmic tails of Ig- and Ig- (QTAT, DCSM, or flanking
sequences) may interact with distinct intracellular effectors, which
are specifically recruited by receptor aggregation and thus determine
the activation of different intracellular signaling pathways. However,
the fact that the deletion of one of the flanking sequences is enough
to allow Ig- to trigger IL-2 secretion after stimulation (data not
shown) supports a conformational role for the flanking sequences.
The signaling activity of the BCR-associated subunits can be regulated
by cross-linking of mIg with FcR (22, 26) involving the phosphatase
PTP1C, which acts as a trans-regulator of the Ig- /Ig- ITAM
activity (27). Our results show that QTAT or flanking sequences
regulate Ig- ITAM signaling activities, meaning that these
activating motifs can be regulated in a cis-position. It remains to
establish what is the function of these sequences in the whole BCR
complex and whether cytoplasmic ligands of Ig- cytoplasmic tail may
regulate the signaling activity carry out by Ig- cytoplasmic tail,
as is suggested by results showing that mIg stimulation of spleen B
cells could trigger calcium oscillations (28). During B cell activation
and differentiation, BCR composition may vary because heterodimers with
cytoplasmic deleted isoforms of Ig- or Ig- have been reported
(29, 30). The heterodimers that contain one of these deleted forms
therefore probably have the signaling capacities of either Ig- or
Ig- . Variations in cytosol composition could also determine the
activation of one chain more than the other or could trigger different
events depending on the effectors present in the cells, like for Ig-
chimeras in T cells that are able to induce IL-2 secretion (17, 20).
The analysis of relative signaling capacities of Ig- and Ig- and
their peptide sequence requirement is a first step in understanding BCR
signaling events during the different stages of B cell differentiation
or activation.
FOOTNOTES
*
This work was supported by the Institut National pour la
Santé et la Recherche Médicale and the Institut Curie.
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
``advertisement'' in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Supported by a fellowship from the Ministère de la Recherche
et des Techniques and the Association de la Recherche contre le
Cancer.
¶
Address correspondence to: CJF 95-01, Institut Curie, 12 rue
Lhomond, 75231 Paris cedex 05, France. Tel.: 33-1-42-34-63-88; Fax:
33-1-42-34-63-82; E-mail: bonnerot{at}curie.fr.
''
Present address: Duke University, Durham, NC.
1
The abbreviations used are: BCR, B cell antigen
receptor(s); mIg, membrane immunoglobulin; IL-2, interleukin-2; FcR,
Fc RII; m, motif.
Acknowledgments
We thank D. Lankar and M. A. Marloie for
excellent technical participation and Dr. M. Partiseti and Dr. J. Verheugen for help in the calcium studies. We thank Dr. S. Amigorena
and Dr. J. Salamero for advice during manuscript preparation.
REFERENCES
-
Gold, M. R.,
Matsuuchi, L.,
Kelly, R. B.,
DeFranco, A. L.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
3436-3440
[Abstract/Free Full Text]
-
Campbell, K. S.,
Cambier, J. C.
(1990)
EMBO J.
9,
441-448
[Medline]
[Order article via Infotrieve]
-
Yamanashi, Y.,
Kakiuchi, T.,
Mizuguchi, J.,
Yamamoto, T.,
Toyoshima, K.
(1991)
Science
251,
192-194
[Abstract/Free Full Text]
-
Burkhardt, A. L.,
Brunswick, M.,
Bolen, J. B.,
Mond, J. J.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
7410-7414
[Abstract/Free Full Text]
-
Lin, J.,
Justement, L. B.
(1992)
J. Immunol.
149,
1548-1555
[Abstract]
-
Campbell, M. A.,
Sefton, B. M.
(1992)
Mol. Cell. Biol.
12,
2315-2321
[Abstract/Free Full Text]
-
Hutchcroft, J. E.,
Harrison, M. L.,
Geahlen, R. L.
(1992)
J. Biol. Chem.
267,
8613-8619
[Abstract/Free Full Text]
-
Yamada, T.,
Taniguchi, T.,
Yang, C.,
Yasue, S.,
Saito, H.,
Yamamura, H.
(1993)
Eur. J. Biochem.
213,
455-459
[Medline]
[Order article via Infotrieve]
-
Clark, M. R.,
Campbell, K. S.,
Kazlauskas, A.,
Johnson, S. A.,
Hertz, M.,
Potter, T. A.,
Pleiman, C.,
Cambier, J. C.
(1992)
Science
258,
123-126
[Abstract/Free Full Text]
-
Baixeras, E.,
Kroemer, G.,
Cuende, E.,
Marquez, C.,
Bosca, L.,
Martinez, J. E. A.,
Martinez, A.-C.
(1993)
Immunol. Rev.
132,
5-47
[CrossRef][Medline]
[Order article via Infotrieve]
-
Gelfand, E. W.,
Cheung, R. K.,
Mills, G. B.,
Grinstein, S.
(1988)
Eur. J. Immunol.
18,
917-922
[Medline]
[Order article via Infotrieve]
-
Dennis, G. J.,
Mizuguchi, J.,
McMillan, V.,
Finkelman, F. D.,
Ohara, J.,
Mond, J. J.
(1987)
J. Immunol.
138,
4307-4312
[Abstract]
-
Reth, M.
(1989)
Nature
338,
383-384
[Medline]
[Order article via Infotrieve]
-
Clark, M. R.,
Johnson, S. A.,
Cambier, J. C.
(1994)
EMBO J.
13,
1911-1919
[Medline]
[Order article via Infotrieve]
-
Sanchez, M.,
Misulovin, Z.,
Burkhardt, A. L.,
Mahajan, S.,
Costa, T.,
Franke, R.,
Bolen, J. B.,
Nussenzweig, M.
(1993)
J. Exp. Med.
178,
1049-1055
[Abstract/Free Full Text]
-
Kim, K. M.,
Alber, G.,
Weiser, P.,
Reth, M.
(1993)
Eur. J. Immunol.
23,
911-916
[Medline]
[Order article via Infotrieve]
-
Taddie, J. A.,
Hurley, T. R.,
Hardwick, B. S.,
Sefton, B. M.
(1994)
J. Biol. Chem.
269,
13529-13535
[Abstract/Free Full Text]
-
Choquet, D.,
Ku, G.,
Cassard, S.,
Malissen, B.,
Korn, H.,
Fridman, W. H.,
Bonnerot, C.
(1994)
J. Biol. Chem.
269,
6491-6497
[Abstract/Free Full Text]
-
Flaswinkel, H.,
Reth, M.
(1994)
EMBO J.
13,
83-89
[Medline]
[Order article via Infotrieve]
-
Burkhardt, A. L.,
Costa, T.,
Misulovin, Z.,
Stealy, B.,
Bolen, J. B.,
Nussenzweig, M.
(1994)
Mol. Cell. Biol.
14,
1095-1103
[Abstract/Free Full Text]
-
Williams, G. T.,
Peaker, C. J. G.,
Patel, K. J.,
Neuberger, M. S.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
474-478
[Abstract/Free Full Text]
-
Amigorena, S.,
Bonnerot, C.,
Drake, J. R.,
Choquet, D.,
Hunziker, W.,
Guillet, J.-G.,
Webster, P.,
Sautes, C.,
Mellman, I.,
Fridman, W. H.
(1992)
Science
256,
1808-1812
[Abstract/Free Full Text]
-
Choquet, D.,
Partiseti, M.,
Amigorena, S.,
Bonnerot, C.,
Fridman, W. H.,
Korn, H.
(1993)
J. Cell. Biol.
121,
355-363
[Abstract/Free Full Text]
-
Diegel, M. L.,
Rankin, B. M.,
Bolen, J. B.,
Dubois, P. M.,
Kiener, P. A.
(1994)
J. Biol. Chem.
269,
11409-11416
[Abstract/Free Full Text]
-
Law, D. A.,
Chan, V. W. F.,
Datta, S. K.,
DeFranco, A. L.
(1993)
Curr. Biol.
3,
645-657
-
Muta, T.,
Kurosaki, T.,
Misulovin, Z.,
Sanchez, M.,
Nussenzweig, C.,
Ravetch, J. V.
(1994)
Nature
368,
70-73
[CrossRef][Medline]
[Order article via Infotrieve]
-
D'Ambrosio, D.,
Hippen, K. H.,
Minskoff, S. A.,
Mellman, I.,
Pani, G.,
Siminovitch, K. A.,
Cambier, J. C.
(1995)
Science
268,
293-297
[Abstract/Free Full Text]
-
Wilson, H. A.,
Greenblatt, D.,
Poenie, M.,
Finkelman, F. D.,
Tsien, R.
(1987)
J. Exp. Med.
166,
601-606
[Abstract/Free Full Text]
-
Friedrich, R. J.,
Campbell, K. S.,
Cambier, J. C.
(1993)
J. Immunol.
150,
2814-2822
[Abstract]
-
Ishihara, K.,
Wood, W. J., Jr.,
Wall, R.,
Sakaguchi, N.,
Michnoff, C.,
Tucker, P. W.,
Kincade, P. W.
(1993)
J. Immunol.
150,
2253-2262
[Abstract]
-
Unkeless, X.
(1979)
J. Exp. Med.
150,
580-596
[Abstract/Free Full Text]
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Gazumyan, A. Reichlin, and M. C. Nussenzweig
Ig{beta} tyrosine residues contribute to the control of B cell receptor signaling by regulating receptor internalization
J. Exp. Med.,
July 10, 2006;
203(7):
1785 - 1794.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Pike and M. J. H. Ratcliffe
Dual Requirement for the Ig{alpha} Immunoreceptor Tyrosine-Based Activation Motif (ITAM) and a Conserved Non-Ig{alpha} ITAM Tyrosine in Supporting Ig{alpha}{beta}-Mediated B Cell Development
J. Immunol.,
February 15, 2005;
174(4):
2012 - 2020.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Fuentes-Panana, G. Bannish, N. Shah, and J. G. Monroe
Basal Ig{alpha}/Ig{beta} Signals Trigger the Coordinated Initiation of Pre-B Cell Antigen Receptor-Dependent Processes
J. Immunol.,
July 15, 2004;
173(2):
1000 - 1011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Pike, S. Iacampo, J. E. Friedmann, and M. J. H. Ratcliffe
The Cytoplasmic Domain of Ig{alpha} Is Necessary and Sufficient to Support Efficient Early B Cell Development
J. Immunol.,
February 15, 2004;
172(4):
2210 - 2218.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. van Lent, K. C. Nabbe, P. Boross, A. B. Blom, J. Roth, A. Holthuysen, A. Sloetjes, S. Verbeek, and W. van den Berg
The Inhibitory Receptor Fc{gamma}RII Reduces Joint Inflammation and Destruction in Experimental Immune Complex-Mediated Arthritides Not Only by Inhibition of Fc{gamma}RI/III but Also by Efficient Clearance and Endocytosis of Immune Complexes
Am. J. Pathol.,
November 1, 2003;
163(5):
1839 - 1848.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kabak, B. J. Skaggs, M. R. Gold, M. Affolter, K. L. West, M. S. Foster, K. Siemasko, A. C. Chan, R. Aebersold, and M. R. Clark
The Direct Recruitment of BLNK to Immunoglobulin {alpha} Couples the B-Cell Antigen Receptor to Distal Signaling Pathways
Mol. Cell. Biol.,
April 15, 2002;
22(8):
2524 - 2535.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Bannish, E. M. Fuentes-Panana, J. C. Cambier, W. S. Pear, and J. G. Monroe
Ligand-independent Signaling Functions for the B Lymphocyte Antigen Receptor and Their Role in Positive Selection during B Lymphopoiesis
J. Exp. Med.,
November 26, 2001;
194(11):
1583 - 1596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kraus, L. I. Pao, A. Reichlin, Y. Hu, B. Canono, J. C. Cambier, M. C. Nussenzweig, and K. Rajewsky
Interference with Immunoglobulin (Ig){alpha} Immunoreceptor Tyrosine-based Activation Motif (ITAM) Phosphorylation Modulates or Blocks B Cell Development, Depending on the Availability of an Ig{beta} Cytoplasmic Tail
J. Exp. Med.,
August 20, 2001;
194(4):
455 - 470.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kouro, K. Nagata, S. Takaki, S. Nisitani, M. Hirano, M. I. Wahl, O. N. Witte, H. Karasuyama, and K. Takatsu
Bruton's tyrosine kinase is required for signaling the CD79b-mediated pro-B to pre-B cell transition
Int. Immunol.,
April 1, 2001;
13(4):
485 - 493.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Lankar, V. Briken, K. Adler, P. Weiser, S. Cassard, U. Blank, M. Viguier, and C. Bonnerot
Syk Tyrosine Kinase and B Cell Antigen Receptor (BCR) Immunoglobulin-alpha Subunit Determine BCR-mediated Major Histocompatibility Complex Class II-restricted Antigen Presentation
J. Exp. Med.,
September 7, 1998;
188(5):
819 - 831.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Cassard, J. Salamero, D. Hanau, D. Spehner, J. Davoust, W. H. Fridman, and C. Bonnerot
A Tyrosine-Based Signal Present in Ig {alpha} Mediates B Cell Receptor Constitutive Internalization
J. Immunol.,
February 15, 1998;
160(4):
1767 - 1773.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-M. Teh and M. S. Neuberger
The Immunoglobulin (Ig)alpha and Igbeta Cytoplasmic Domains Are Independently Sufficient to Signal B Cell Maturation and Activation in Transgenic Mice
J. Exp. Med.,
May 19, 1997;
185(10):
1753 - 1758.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|